222 related articles for article (PubMed ID: 26062750)
1. Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis.
Lester-Coll NH; Lee JM; Gogineni K; Hwang WT; Schwartz JS; Prosnitz RG
Breast Cancer Res Treat; 2015 Jul; 152(1):217-226. PubMed ID: 26062750
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes after contralateral prophylactic mastectomy: a decision analysis.
Portschy PR; Kuntz KM; Tuttle TM
J Natl Cancer Inst; 2014 Aug; 106(8):. PubMed ID: 25031308
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).
Davies KR; Brewster AM; Bedrosian I; Parker PA; Crosby MA; Peterson SK; Shen Y; Volk RJ; Cantor SB
Breast Cancer Res; 2016 Sep; 18(1):93. PubMed ID: 27650678
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis.
Wong SM; Stout NK; Punglia RS; Prakash I; Sagara Y; Golshan M
Cancer; 2017 Jul; 123(14):2609-2617. PubMed ID: 28221673
[TBL] [Abstract][Full Text] [Related]
5. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
6. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.
Keskey RC; LaJoie AS; Sutton BS; Kim IK; Cheadle WG; McMasters KM; Ajkay N
Ann Surg Oncol; 2017 Dec; 24(13):3903-3910. PubMed ID: 29039025
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
[TBL] [Abstract][Full Text] [Related]
9. National trends in contralateral prophylactic mastectomy in women with locally advanced breast cancer.
Panchal H; Pilewskie ML; Sheckter CC; Albornoz CR; Razdan SN; Disa JJ; Cordeiro PG; Mehrara BJ; Matros E
J Surg Oncol; 2019 Jan; 119(1):79-87. PubMed ID: 30480805
[TBL] [Abstract][Full Text] [Related]
10. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
[TBL] [Abstract][Full Text] [Related]
11. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
12. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
13. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
[TBL] [Abstract][Full Text] [Related]
14. Rising Rates of Contralateral Prophylactic Mastectomy as a Treatment for Early-Stage Breast Cancer.
Jerome-DʼEmilia B; Kushary D; Suplee PD
Cancer Nurs; 2019; 42(1):12-19. PubMed ID: 29251681
[TBL] [Abstract][Full Text] [Related]
15. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer.
Roberts A; Habibi M; Frick KD
Ann Surg Oncol; 2014 Jul; 21(7):2209-17. PubMed ID: 24633665
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer.
Zendejas B; Moriarty JP; O'Byrne J; Degnim AC; Farley DR; Boughey JC
J Clin Oncol; 2011 Aug; 29(22):2993-3000. PubMed ID: 21690472
[TBL] [Abstract][Full Text] [Related]
18. Contralateral prophylactic mastectomy rate and predictive factors among patients with breast cancer who underwent multigene panel testing for hereditary cancer.
Elsayegh N; Webster RD; Gutierrez Barrera AM; Lin H; Kuerer HM; Litton JK; Bedrosian I; Arun BK
Cancer Med; 2018 Jun; 7(6):2718-2726. PubMed ID: 29733510
[TBL] [Abstract][Full Text] [Related]
19. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
[TBL] [Abstract][Full Text] [Related]
20. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer.
Brewster AM; Parker PA
Oncologist; 2011; 16(7):935-41. PubMed ID: 21672945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
